https://www.drugtargetreview.com/article/108293/ovarian-cancer-breakthrough-the-potential-of-rhenium-tricarbonyl-trip-as-a-promising-anti-tumour-drug/
0
0
Ovarian cancer breakthrough: the potential of rhenium tricarbonyl (TRIP) as a promising anti-tumour drug - Drug Target Review
2/8/23 at 10:16am
Organization
Drug Target Review
Authors
Details
38 words
Summarize
Cancer Health Women's Health Ovarian cancer breakthrough rhenium tricarbonyl ovarian cancer research Institute Krems Bioanalytics Izzy Wood
In this exclusive article, Drug Target Review’s Izzy Wood highlights innovative ovarian cancer research from the Institute Krems Bioanalytics.
Create an account or login to join the discussion